Literature DB >> 20218014

Effect of plasma protein and tissue binding on the time course of drug concentration in plasma.

P J McNamara1, G Levy, M Gibaldi.   

Abstract

We have studied by digital computer simulation the effect of concentration-dependent plasma protein and tissue binding on the time course of drug concentrations (both unbound and total) in plasma following rapid injection of a drug whose elimination rate is proportional to either free or total drug concentration in plasma, assuming instantaneous equilibration of the drug between vascular and nonvascular spaces. The following observations were made when elimination rate was assumed to be a function of free drug concentration: (a) when plasma protein binding is nonlinear and there is either no tissue binding or linear tissue binding, log concentration-time plots of free drug are always concave whereas such plots for total (sum of free and bound) drug can be convex, almost linear, or concave (apparently biexponential) depending on the plasma protein binding parameters relative to the initial concentration; (b) linear tissue binding in association with nonlinear plasma protein binding can reduce the concavity or enhance the convexity of log total concentration-time plots. When drug elimination rate was assumed to be a function of total concentration in plasma, nonlinear plasma protein binding in association with linear or no tissue binding yielded convex log total concentration-time plots which could sometimes be described by Michaelis-Menten kinetics. In general, drug concentration-dependent changes in the apparent volume of distribution resulting from nonlinear plasma protein and (where applicable) tissue binding have a pronounced effect on the slope of log total plasma concentration-time plots. It appears that under clinically realistic conditions an otherwise marked curvature of such plots, due to nonlinear plasma protein binding, may in fact be dampened or overcome by linear tissue binding.

Mesh:

Substances:

Year:  1979        PMID: 20218014     DOI: 10.1007/bf01059738

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  12 in total

1.  Commentary: a physiological approach to hepatic drug clearance.

Authors:  G R Wilkinson; D G Shand
Journal:  Clin Pharmacol Ther       Date:  1975-10       Impact factor: 6.875

2.  Critical evaluation of use of effective protein fractions in developing pharmacokinetic models for drug distribution.

Authors:  D Shen; M Gibaldi
Journal:  J Pharm Sci       Date:  1974-11       Impact factor: 3.534

3.  Letter: Effect of plasma protein binding on elimination of warfarin.

Authors:  G Levy; A Yacobi
Journal:  J Pharm Sci       Date:  1974-05       Impact factor: 3.534

4.  Numerical solution of nonlinear pharmacokinetic equations: effects of plasma protein binding on drug distribution and elimination.

Authors:  J J Coffey; F J Bullock; P T Schoenemann
Journal:  J Pharm Sci       Date:  1971-11       Impact factor: 3.534

5.  Comparative pharmacokinetics of coumarin anticoagulants XXXVII: Simultaneous in vivo displacement of dicumarol from serum protein and tissue binding sites by tolbutamide in rats.

Authors:  C M Lai; G Levy
Journal:  J Pharm Sci       Date:  1978-10       Impact factor: 3.534

6.  Comparative pharmacokinetics of coumarin anticoagulants XXXII: Interindividual differences in binding of warfarin and dicumarol in rat liver and implications for physiological pharmacokinetic modeling.

Authors:  G Levy; C M Lai; A Yacobi
Journal:  J Pharm Sci       Date:  1978-02       Impact factor: 3.534

7.  Effect of plasma protein and tissue binding on the biologic half-life of drugs.

Authors:  M Gibaldi; G Levy; P J McNamara
Journal:  Clin Pharmacol Ther       Date:  1978-07       Impact factor: 6.875

8.  Pharmacokinetic models regarding protein binding of drugs.

Authors:  E Krüger-Thiemer; W Diller; P Bünger
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1965

9.  Kinetics of elimination of drugs possessing high affinity for the plasma proteins.

Authors:  B K Martin
Journal:  Nature       Date:  1965-08-28       Impact factor: 49.962

10.  Drug displacement from protein binding: source of the sulphadoxine liberated by phenylbutazone.

Authors:  W M Wardell
Journal:  Br J Pharmacol       Date:  1971-10       Impact factor: 8.739

View more
  21 in total

Review 1.  Age-related changes in protein binding of drugs: implications for therapy.

Authors:  M K Grandison; F D Boudinot
Journal:  Clin Pharmacokinet       Date:  2000-03       Impact factor: 6.447

2.  Pharmacokinetics, antitumor and cardioprotective effects of liposome-encapsulated phenylaminoethyl selenide in human prostate cancer rodent models.

Authors:  Jeong Yeon Kang; Mathew Eggert; Shravanthi Mouli; Ibrahim Aljuffali; Xiaoyu Fu; Ben Nie; Amy Sheil; Kendall Waddey; Charlie D Oldham; Sheldon W May; Rajesh Amin; Robert D Arnold
Journal:  Pharm Res       Date:  2014-08-27       Impact factor: 4.200

3.  Effect of repetitive administration of Doxorubicin-containing liposomes on plasma pharmacokinetics and drug biodistribution in a rat brain tumor model.

Authors:  Robert D Arnold; Donald E Mager; Jeanine E Slack; Robert M Straubinger
Journal:  Clin Cancer Res       Date:  2005-12-15       Impact factor: 12.531

4.  Volumes of distribution and mean residence time of drugs with linear tissue distribution and binding and nonlinear protein binding.

Authors:  H Cheng; W R Gillespie
Journal:  J Pharmacokinet Biopharm       Date:  1996-08

5.  Pharmacokinetics of an ACE inhibitor, S-9780, in man: evidence of tissue binding.

Authors:  K R Lees; A W Kelman; J L Reid; B Whiting
Journal:  J Pharmacokinet Biopharm       Date:  1989-10

6.  Effect of albumin distribution. A simulation analysis of the effect of altered albumin distribution on the apparent volume of distribution and apparent elimination rate constant of drugs.

Authors:  M Shimoda; E Kokue; T Hayama; T B Vree
Journal:  Pharm Weekbl Sci       Date:  1989-06-23

7.  Accumulation kinetics of drugs with nonlinear plasma protein and tissue binding characteristics.

Authors:  P J McNamara; J T Slattery; M Gibaldi; G Levy
Journal:  J Pharmacokinet Biopharm       Date:  1979-08

8.  Generalized pharmacokinetic modeling for drugs with nonlinear binding: I. Theoretical framework.

Authors:  W R Gillespie
Journal:  J Pharmacokinet Biopharm       Date:  1993-02

9.  Fractions metabolized in a triangular metabolic system: cinromide and two metabolites in the rhesus monkey.

Authors:  E A Lane; R H Levy
Journal:  J Pharmacokinet Biopharm       Date:  1985-08

10.  A Pharmacokinetic and Pharmacodynamic Study of Intravenous Levosimendan in Healthy Chinese Volunteers and Ethnic Comparisons.

Authors:  Kai-Min Chu; Yoa-Pu Hu; Jun-Ting Liou
Journal:  Acta Cardiol Sin       Date:  2014-07       Impact factor: 2.672

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.